MGC Pharmaceuticals Ltd (ASX:MXC) is a European based bio-pharma company developing and supplying affordable standardised phytocannabinoid derived medicines.
The company is focused on its core business of executing its growth strategy and become a world-leading, vertically integrated, biopharma company focused on the development and production of phytocannabinoid derived medications for targeted global markets.
London's cannabis sector is finally budding two decades after GW Pharma blazed a trail, with debutants MGC Pharmaceuticals and Kanabo Group both warmly welcomed after listing this month